Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Sale
+$47,912
-37.43%
Shares
Shares Volume: 12,477 Shares
Average Share Price: $3.84
INSIDER
Foster Wayne
EVP, Chief Accounting Officer (Officer)
reported on Feb 2 2024
traded on Jan 31 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 20,857 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $47,911.68 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $49,056 |
| COMPANY PREVIOUS TRADES |